UB Paderborn / Katalog / Suche / in CDI

Non-melanoma skin cancer

The Lancet (British edition), 2010-02, Vol.375 (9715), p.673-685

2010

Link zum Volltext

Verfügbarkeit prüfen

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.113-125.e5

2016

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic Therapy and Non-Melanoma Skin Cancer

Cancers, 2016-10, Vol.8 (10), p.98

2016

Link zum Volltext

Verfügbarkeit prüfen

A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity

Acta dermato-venereologica, 2017-10, Vol.97 (9), p.1108-1113

2017

Link zum Volltext

Verfügbarkeit prüfen

Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management

Acta dermato-venereologica, 2017-09, Vol.97 (8), p.997-998

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia

Clinical cancer research, 2008-08, Vol.14 (16), p.5292-5299

2008

Link zum Volltext

Verfügbarkeit prüfen

Oral Hedgehog-Pathway Inhibitors for Basal-Cell Carcinoma

The New England journal of medicine, 2012-06, Vol.366 (23), p.2225-2226

Lear, John T

2012

Link zum Volltext

Verfügbarkeit prüfen

Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases

Plastic and reconstructive surgery. Global open, 2017-07, Vol.5 (7), p.e1424-e1424

2017

Link zum Volltext

Verfügbarkeit prüfen

Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma

Oncotarget, 2021-12, Vol.12 (26), p.2531-2540

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between functional polymorphism in EGF gene and malignant melanoma

The Lancet (British edition), 2002-02, Vol.359 (9304), p.397-401

2002

Link zum Volltext

Verfügbarkeit prüfen

Emerging trends in the treatment of advanced basal cell carcinoma

Cancer treatment reviews, 2018-03, Vol.64, p.1-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-melanoma skin cancer

Clinical medicine (London, England), 2016-02, Vol.16 (1), p.62-65

2016

Link zum Volltext

Verfügbarkeit prüfen

Sequential Treatment of Multiple Actinic Keratoses with Solaraze and Actikerall

Case reports in dermatology, 2014-07, Vol.6 (2), p.164-168

2014

Link zum Volltext

Verfügbarkeit prüfen

What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes

Journal of the European Academy of Dermatology and Venereology, 2017-03, Vol.31 (S2), p.3-4

Lear, John T.

2017

Link zum Volltext

Verfügbarkeit prüfen

First evidence of genotype-phenotype correlations in Gorlin syndrome

Journal of medical genetics, 2017-08, Vol.54 (8), p.530

2017

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based treatment for low-risk basal cell carcinoma

The lancet oncology, 2014, Vol.15 (1), p.12-13

Lear, John T

2014

Link zum Volltext

Verfügbarkeit prüfen

Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study

EJD. European journal of dermatology, 2023-06, Vol.33 (3), p.280-286

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors

Journal of the American Academy of Dermatology, 2005-03, Vol.52 (3), p.468-473

2005

Link zum Volltext

Verfügbarkeit prüfen

Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)

British journal of dermatology (1951), 2022-09, Vol.187 (3), p.324-337

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma

Journal of the American Academy of Dermatology, 2009-08, Vol.61 (2), p.247-251

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma

Expert review of clinical pharmacology, 2023-12, Vol.16 (12), p.1211-1220

2023

Link zum Volltext

Verfügbarkeit prüfen

Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma

Future oncology (London, England), 2017-01, Vol.13 (2), p.175-184

2017

Link zum Volltext

Verfügbarkeit prüfen

Focus on Basal Cell Carcinoma

Journal of Skin Cancer, 2011-01, Vol.2011, p.328615-5

2011

Link zum Volltext

Verfügbarkeit prüfen

Melanoma in Organ Transplant Recipients: Incidence, Outcomes and Management Considerations

Journal of Skin Cancer, 2012-01, Vol.2012, p.404615-5

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Non-melanoma skin cancer

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Photodynamic Therapy and Non-Melanoma Skin Cancer

A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity

Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial

Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management

Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia

Oral Hedgehog-Pathway Inhibitors for Basal-Cell Carcinoma

Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases

Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma

Association between functional polymorphism in EGF gene and malignant melanoma

Emerging trends in the treatment of advanced basal cell carcinoma

Non-melanoma skin cancer

Sequential Treatment of Multiple Actinic Keratoses with Solaraze and Actikerall

What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes

First evidence of genotype-phenotype correlations in Gorlin syndrome

Evidence-based treatment for low-risk basal cell carcinoma

Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study

Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors

Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)

Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma

Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma

Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma

Focus on Basal Cell Carcinoma

Melanoma in Organ Transplant Recipients: Incidence, Outcomes and Management Considerations

Suchergebnisse filtern